Product Information

SPRYCEL 100 MG TABLET is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $591.1812 per EA under NDC 00003085222. Its NADAC has been published 645 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the dasatinib market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

SPRYCEL 100 MG TABLET

dasatinib
$591.1812per EA
High Outlier

Strength

100 mg/1

NDC

00003085222

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

5/20/2026

Active Ingredients

DASATINIB

Approval Type

New Drug (NDA)

FDA Application

NDA021986

On Market Since

5/30/2008

Pharmacological Classes

Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor
Protein Kinase Inhibitors

Price Statistics

The NADAC for SPRYCEL 100 MG TABLET has been published 645 times since Nov 28, 2013, and over the history we have for it it has risen 103.9%. The table below summarizes its recorded NADAC range and movement.

Current price$591.1812 per EA
All-time high$591.4984 (Jul 16, 2025)
All-time low$283.1137 (Dec 18, 2013)
52-week high$591.4984
52-week low$590.4716
Median price$466.0697
Average price$452.0451
Largest weekly change+7.5% (Mar 25, 2015)
Weeks tracked645
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

+0.0%

6M

+0.1%

1Y

-0.1%

3Y

+9.2%

5Y

+21.4%

All

+103.9%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SPRYCEL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SPRYCEL 100 MG TABLET, manufactured by E.R. Squibb & Sons, L.L.C., is $591.1812 per EA (NDC 00003085222), effective Jun 24, 2026.

How has the price of SPRYCEL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for SPRYCEL 100 MG TABLET has risen 103.9%. It has been tracked across 645 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SPRYCEL 100 MG TABLET?

Since Nov 28, 2013, the NADAC for SPRYCEL 100 MG TABLET has ranged from a low of $283.1137 (Dec 18, 2013) to a high of $591.4984 (Jul 16, 2025), with a median of $466.0697 per EA.

Are there cheaper alternatives to SPRYCEL 100 MG TABLET?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DASATINIB 100 MG TABLET, is $26.3180 per EA — about 96% below SPRYCEL 100 MG TABLET.

Who manufactures SPRYCEL 100 MG TABLET?

SPRYCEL 100 MG TABLET (NDC 00003085222) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.